Sana Biotechnology Inc (NAS:SANA)
$ 6.65 -0.27 (-3.9%) Market Cap: 1.47 Bil Enterprise Value: 1.33 Bil PE Ratio: 0 PB Ratio: 3.91 GF Score: 39/100

Sana Biotechnology Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 09:00PM GMT
Release Date Price: $24.77
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good afternoon, everybody. Thanks for joining us for the next session here today. Very pleased to have Sana with us for the session. Quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

And from Sana, we have Steve Harr, the CEO, joining with us. Steve, I'm going to turn it over to you to make some opening comments, and then we'll go right into Q&A.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

Great. Thank you, Matthew. And since you made your disclosures, I'll do mine quickly, which is we'll probably be making forward-looking statements. And we and our lawyers, spend a bunch of time on the risk factors in the queue. So take a look at those before you make any decisions that can be very helpful in understanding our risks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot